Concepts (281)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serum Amyloid A Protein | 21 | 2024 | 44 | 4.120 |
Why?
|
| Lipoproteins, HDL | 16 | 2021 | 117 | 3.720 |
Why?
|
| Group X Phospholipases A2 | 6 | 2016 | 8 | 1.900 |
Why?
|
| Apolipoproteins E | 10 | 2024 | 201 | 1.670 |
Why?
|
| Atherosclerosis | 12 | 2023 | 1006 | 1.370 |
Why?
|
| Group V Phospholipases A2 | 5 | 2017 | 5 | 1.370 |
Why?
|
| Aortic Aneurysm, Abdominal | 6 | 2024 | 425 | 1.210 |
Why?
|
| Angiotensin II | 5 | 2024 | 163 | 1.210 |
Why?
|
| Phospholipases A | 5 | 2007 | 36 | 1.150 |
Why?
|
| Lipoproteins, LDL | 7 | 2013 | 133 | 1.140 |
Why?
|
| Mice, Inbred C57BL | 28 | 2024 | 4758 | 1.030 |
Why?
|
| Inflammation | 8 | 2022 | 1522 | 1.010 |
Why?
|
| Hepatocytes | 6 | 2020 | 239 | 1.000 |
Why?
|
| Insulin-Secreting Cells | 2 | 2017 | 146 | 0.880 |
Why?
|
| Adrenal Glands | 2 | 2015 | 46 | 0.780 |
Why?
|
| Cholesterol | 9 | 2022 | 559 | 0.770 |
Why?
|
| Mice, Knockout | 17 | 2024 | 3868 | 0.760 |
Why?
|
| Phospholipases A2, Secretory | 2 | 2015 | 4 | 0.760 |
Why?
|
| Mice | 35 | 2024 | 18509 | 0.750 |
Why?
|
| Acute-Phase Reaction | 4 | 2017 | 11 | 0.750 |
Why?
|
| Receptors, LDL | 3 | 2009 | 104 | 0.730 |
Why?
|
| CD36 Antigens | 3 | 2007 | 42 | 0.700 |
Why?
|
| Animals | 46 | 2024 | 34854 | 0.690 |
Why?
|
| Macrophages | 9 | 2018 | 692 | 0.690 |
Why?
|
| Apolipoprotein A-I | 9 | 2020 | 89 | 0.680 |
Why?
|
| Scavenger Receptors, Class B | 6 | 2016 | 12 | 0.560 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 128 | 0.530 |
Why?
|
| Aortic Diseases | 4 | 2020 | 197 | 0.520 |
Why?
|
| Aorta | 5 | 2023 | 552 | 0.510 |
Why?
|
| Lipoproteins | 5 | 2011 | 187 | 0.510 |
Why?
|
| Inflammasomes | 1 | 2018 | 166 | 0.500 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 516 | 0.460 |
Why?
|
| Furin | 1 | 2015 | 9 | 0.460 |
Why?
|
| Arteriosclerosis | 3 | 2005 | 123 | 0.460 |
Why?
|
| Proprotein Convertases | 1 | 2015 | 26 | 0.460 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2015 | 90 | 0.450 |
Why?
|
| ATP-Binding Cassette Transporters | 4 | 2015 | 197 | 0.430 |
Why?
|
| Cyclooxygenase 2 | 1 | 2014 | 127 | 0.430 |
Why?
|
| Steroids | 1 | 2015 | 174 | 0.420 |
Why?
|
| Cholesterol, HDL | 3 | 2016 | 398 | 0.420 |
Why?
|
| Insulin | 2 | 2017 | 1168 | 0.400 |
Why?
|
| Proteoglycans | 4 | 2018 | 92 | 0.370 |
Why?
|
| Lipase | 1 | 2011 | 97 | 0.350 |
Why?
|
| Macrophages, Peritoneal | 3 | 2009 | 39 | 0.330 |
Why?
|
| Group II Phospholipases A2 | 5 | 2016 | 9 | 0.310 |
Why?
|
| Adipogenesis | 1 | 2010 | 80 | 0.310 |
Why?
|
| Foam Cells | 2 | 2009 | 24 | 0.310 |
Why?
|
| Extracellular Matrix | 3 | 2020 | 237 | 0.310 |
Why?
|
| Endocytosis | 2 | 2007 | 126 | 0.300 |
Why?
|
| Phosphoproteins | 2 | 2016 | 443 | 0.300 |
Why?
|
| Liver | 4 | 2021 | 1797 | 0.300 |
Why?
|
| Apolipoproteins B | 2 | 2013 | 140 | 0.290 |
Why?
|
| Down-Regulation | 1 | 2010 | 679 | 0.280 |
Why?
|
| Disease Models, Animal | 11 | 2024 | 4690 | 0.280 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 2442 | 0.270 |
Why?
|
| Dinoprostone | 3 | 2017 | 70 | 0.270 |
Why?
|
| Cells, Cultured | 8 | 2017 | 3046 | 0.270 |
Why?
|
| COS Cells | 4 | 2011 | 268 | 0.270 |
Why?
|
| Cell Line | 4 | 2017 | 2724 | 0.270 |
Why?
|
| Myocardium | 1 | 2012 | 907 | 0.270 |
Why?
|
| Aortic Aneurysm | 2 | 2020 | 237 | 0.260 |
Why?
|
| Cholesterol Ester Transfer Proteins | 3 | 2023 | 42 | 0.250 |
Why?
|
| Disease Progression | 1 | 2012 | 2233 | 0.240 |
Why?
|
| Immunity, Innate | 1 | 2008 | 413 | 0.240 |
Why?
|
| Islets of Langerhans | 2 | 2017 | 163 | 0.230 |
Why?
|
| Phospholipases A2 | 4 | 2007 | 36 | 0.230 |
Why?
|
| Arachidonic Acid | 2 | 2017 | 67 | 0.220 |
Why?
|
| Fibroblasts | 2 | 2020 | 862 | 0.210 |
Why?
|
| Adenoviridae | 3 | 2014 | 596 | 0.200 |
Why?
|
| Receptors, Lipoprotein | 1 | 2002 | 11 | 0.200 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2015 | 74 | 0.190 |
Why?
|
| Sucrose | 1 | 2022 | 37 | 0.190 |
Why?
|
| Lung Injury | 1 | 2023 | 123 | 0.190 |
Why?
|
| ATP Binding Cassette Transporter 1 | 5 | 2015 | 22 | 0.190 |
Why?
|
| Hydrolysis | 3 | 2009 | 158 | 0.180 |
Why?
|
| Mice, Transgenic | 5 | 2014 | 2451 | 0.180 |
Why?
|
| Humans | 29 | 2024 | 132247 | 0.180 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 127 | 0.180 |
Why?
|
| Cardiovascular Diseases | 2 | 2014 | 2087 | 0.180 |
Why?
|
| Glucose | 2 | 2017 | 871 | 0.180 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 1718 | 0.170 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2010 | 21 | 0.170 |
Why?
|
| Liver X Receptors | 2 | 2010 | 18 | 0.170 |
Why?
|
| Luciferases | 2 | 2010 | 129 | 0.160 |
Why?
|
| Male | 17 | 2024 | 65014 | 0.160 |
Why?
|
| Lipid Metabolism | 4 | 2007 | 382 | 0.160 |
Why?
|
| Signal Transduction | 3 | 2020 | 4720 | 0.160 |
Why?
|
| Aorta, Abdominal | 3 | 2024 | 118 | 0.150 |
Why?
|
| Collagen | 2 | 2012 | 303 | 0.150 |
Why?
|
| Sepsis | 1 | 2023 | 516 | 0.150 |
Why?
|
| Membrane Proteins | 2 | 2007 | 1597 | 0.150 |
Why?
|
| Cathepsin B | 1 | 2018 | 11 | 0.150 |
Why?
|
| Biological Transport | 3 | 2009 | 348 | 0.150 |
Why?
|
| Base Sequence | 2 | 2015 | 2900 | 0.140 |
Why?
|
| Apolipoproteins | 1 | 2018 | 71 | 0.140 |
Why?
|
| Research Personnel | 1 | 2020 | 136 | 0.140 |
Why?
|
| Caspase 1 | 1 | 2018 | 49 | 0.140 |
Why?
|
| Lipopolysaccharides | 2 | 2017 | 306 | 0.140 |
Why?
|
| American Heart Association | 1 | 2020 | 309 | 0.140 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2017 | 12 | 0.140 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 163 | 0.140 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 206 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 2139 | 0.120 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 724 | 0.120 |
Why?
|
| Cholesterol Esters | 2 | 2006 | 16 | 0.120 |
Why?
|
| Intestinal Neoplasms | 1 | 2016 | 40 | 0.120 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 58 | 0.120 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 153 | 0.120 |
Why?
|
| Transfection | 2 | 2010 | 996 | 0.120 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 926 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 1285 | 0.120 |
Why?
|
| HEK293 Cells | 1 | 2018 | 799 | 0.120 |
Why?
|
| Particle Size | 2 | 2013 | 149 | 0.120 |
Why?
|
| Peripheral Arterial Disease | 1 | 2020 | 321 | 0.120 |
Why?
|
| Elastin | 1 | 2015 | 31 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2016 | 422 | 0.110 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2014 | 17 | 0.110 |
Why?
|
| Dietary Fats | 2 | 2009 | 279 | 0.110 |
Why?
|
| Apolipoprotein A-II | 3 | 2016 | 8 | 0.110 |
Why?
|
| Biomarkers | 2 | 2015 | 3404 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2006 | 364 | 0.110 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 689 | 0.110 |
Why?
|
| Crosses, Genetic | 2 | 2005 | 162 | 0.110 |
Why?
|
| Random Allocation | 1 | 2015 | 431 | 0.110 |
Why?
|
| DNA Primers | 1 | 2015 | 636 | 0.110 |
Why?
|
| Proteolysis | 1 | 2015 | 195 | 0.110 |
Why?
|
| Validation Studies as Topic | 1 | 2013 | 13 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2020 | 554 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2015 | 618 | 0.100 |
Why?
|
| Blood Chemical Analysis | 1 | 2013 | 86 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2013 | 136 | 0.100 |
Why?
|
| Hypertension | 1 | 2021 | 1398 | 0.100 |
Why?
|
| Adiposity | 2 | 2013 | 207 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 728 | 0.100 |
Why?
|
| NADPH Oxidase 4 | 1 | 2012 | 14 | 0.100 |
Why?
|
| NADPH Oxidase 2 | 1 | 2012 | 37 | 0.100 |
Why?
|
| Prostaglandins | 1 | 2012 | 43 | 0.100 |
Why?
|
| Gene Expression | 2 | 2010 | 1563 | 0.100 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 590 | 0.090 |
Why?
|
| Intestines | 1 | 2016 | 606 | 0.090 |
Why?
|
| Homeostasis | 1 | 2016 | 722 | 0.090 |
Why?
|
| Forecasting | 1 | 2013 | 373 | 0.090 |
Why?
|
| NADPH Oxidases | 1 | 2012 | 111 | 0.090 |
Why?
|
| Time Factors | 5 | 2013 | 6451 | 0.090 |
Why?
|
| Models, Animal | 1 | 2013 | 469 | 0.090 |
Why?
|
| Risk | 1 | 2013 | 761 | 0.090 |
Why?
|
| Triglycerides | 2 | 2013 | 617 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 1555 | 0.090 |
Why?
|
| Aortic Rupture | 1 | 2012 | 119 | 0.090 |
Why?
|
| Anticholesteremic Agents | 1 | 2013 | 239 | 0.090 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2010 | 5 | 0.090 |
Why?
|
| Biological Transport, Active | 1 | 2010 | 76 | 0.080 |
Why?
|
| Metalloproteases | 1 | 2010 | 15 | 0.080 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2010 | 66 | 0.080 |
Why?
|
| Fibrosis | 1 | 2012 | 421 | 0.080 |
Why?
|
| Corticosterone | 1 | 2010 | 60 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 421 | 0.080 |
Why?
|
| Obesity | 4 | 2024 | 2398 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2511 | 0.080 |
Why?
|
| Lipids | 1 | 2013 | 561 | 0.080 |
Why?
|
| Female | 9 | 2022 | 70787 | 0.080 |
Why?
|
| Interleukins | 1 | 2010 | 129 | 0.080 |
Why?
|
| Sphingomyelins | 1 | 2009 | 15 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 862 | 0.080 |
Why?
|
| Phosphatidylcholines | 1 | 2009 | 39 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 1161 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2010 | 283 | 0.070 |
Why?
|
| Mice, Knockout, ApoE | 2 | 2018 | 5 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1381 | 0.070 |
Why?
|
| Genetic Vectors | 3 | 2014 | 927 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 689 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 3 | 2020 | 473 | 0.070 |
Why?
|
| Protein Binding | 2 | 2018 | 1734 | 0.070 |
Why?
|
| Progesterone | 1 | 2010 | 451 | 0.070 |
Why?
|
| Caveolae | 1 | 2007 | 9 | 0.070 |
Why?
|
| Transferrin | 1 | 2007 | 47 | 0.070 |
Why?
|
| Dynamins | 1 | 2007 | 46 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 224 | 0.070 |
Why?
|
| Ligands | 1 | 2008 | 495 | 0.070 |
Why?
|
| Microtubules | 1 | 2007 | 125 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2014 | 761 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2007 | 269 | 0.060 |
Why?
|
| Biotinylation | 1 | 2006 | 23 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 3018 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 1284 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 327 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2006 | 222 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2008 | 464 | 0.060 |
Why?
|
| Azo Compounds | 1 | 2005 | 11 | 0.060 |
Why?
|
| Lysosomes | 1 | 2007 | 261 | 0.060 |
Why?
|
| Reference Values | 1 | 2007 | 703 | 0.060 |
Why?
|
| Hydrazines | 1 | 2005 | 31 | 0.060 |
Why?
|
| Apoptosis | 1 | 2012 | 1901 | 0.060 |
Why?
|
| Peritoneum | 1 | 2005 | 41 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2005 | 76 | 0.060 |
Why?
|
| Actins | 1 | 2007 | 334 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2010 | 1402 | 0.060 |
Why?
|
| Cytokines | 2 | 2013 | 1365 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2680 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 264 | 0.050 |
Why?
|
| Heparin | 1 | 2005 | 212 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2020 | 189 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2020 | 238 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 341 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2024 | 79 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2004 | 301 | 0.050 |
Why?
|
| Chemokines | 1 | 2023 | 130 | 0.050 |
Why?
|
| Diet, Atherogenic | 1 | 2003 | 16 | 0.050 |
Why?
|
| Receptors, Scavenger | 1 | 2002 | 3 | 0.050 |
Why?
|
| Metabolic Clearance Rate | 1 | 2002 | 131 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2003 | 302 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2022 | 76 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 1 | 2022 | 63 | 0.050 |
Why?
|
| Mutation | 2 | 2020 | 6250 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2005 | 1120 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 258 | 0.040 |
Why?
|
| Doxycycline | 1 | 2022 | 121 | 0.040 |
Why?
|
| Rats | 1 | 2007 | 3607 | 0.040 |
Why?
|
| Adipocytes | 1 | 2022 | 182 | 0.040 |
Why?
|
| Receptors, Angiotensin | 1 | 2020 | 20 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2022 | 255 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 222 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2020 | 89 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2003 | 611 | 0.040 |
Why?
|
| Vascular Remodeling | 1 | 2020 | 54 | 0.040 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2008 | 1175 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2020 | 62 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 2669 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2020 | 151 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 3771 | 0.040 |
Why?
|
| Apolipoprotein B-100 | 1 | 2018 | 38 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 3691 | 0.040 |
Why?
|
| Postprandial Period | 1 | 2018 | 91 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2018 | 143 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2019 | 168 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 232 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2019 | 435 | 0.030 |
Why?
|
| Paneth Cells | 1 | 2016 | 26 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2020 | 526 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2016 | 50 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1556 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2020 | 861 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 205 | 0.030 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 365 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 358 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2015 | 209 | 0.030 |
Why?
|
| Phospholipids | 1 | 2014 | 104 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2166 | 0.030 |
Why?
|
| Organoids | 1 | 2016 | 299 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 630 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 1612 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 623 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 241 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 685 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 326 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 196 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 569 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2013 | 237 | 0.020 |
Why?
|
| Stem Cells | 1 | 2016 | 733 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2013 | 510 | 0.020 |
Why?
|
| Smoking | 1 | 2015 | 940 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 1080 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 541 | 0.020 |
Why?
|
| Receptors, Lipoxin | 1 | 2008 | 1 | 0.020 |
Why?
|
| Biglycan | 1 | 2008 | 7 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2008 | 60 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 540 | 0.020 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2008 | 5 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 2008 | 34 | 0.020 |
Why?
|
| Haplorhini | 1 | 2008 | 117 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1965 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2008 | 152 | 0.020 |
Why?
|
| Kidney | 1 | 2014 | 1338 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 10945 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 275 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 1350 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2005 | 129 | 0.010 |
Why?
|
| United States | 1 | 2020 | 11669 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2005 | 539 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 21482 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 29021 | 0.010 |
Why?
|